APA (7th ed.) Citation

I, D., I, Z., N, A., F, R., M, C., R, R., . . . S, G. (2024). Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis. Metabolites, 14(9), . https://doi.org/10.3390/metabo14090493

Chicago Style (17th ed.) Citation

I, Datta, Zahoor I, Ata N, Rashid F, Cerghet M, Rattan R, Poisson LM, and Giri S. "Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis." Metabolites 14, no. 9 (2024). https://doi.org/10.3390/metabo14090493.

MLA (9th ed.) Citation

I, Datta, et al. "Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis." Metabolites, vol. 14, no. 9, 2024, https://doi.org/10.3390/metabo14090493.